{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 204 - Samir Ounzain - Co-founder & CEO Haya Therapeutics","slug":"episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics","published_at":"2026-07-20T13:37:33+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-204---Samir-Ounzain---Co-founder--CEO-Haya-Therapeutics-e3mac0f","audio_url":"https://anchor.fm/s/f0076084/podcast/play/123071951/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-6-20%2F428278780-44100-2-8aa25eeb10475.mp3","summary":"In this episode of The BioHub by Avetix, I'm joined by Samir Ounzain , CEO and Co-Founder of HAYA Therapeutics . Samir shares the journey from pioneering research into the so-called \"dark genome\" to building one of biotech's most exciting RNA therapeutics companies. We discuss why long non-coding RNAs could unlock an entirely new class of precision medicines, the challenge of turning groundbreaking science into a business, and how HAYA is approaching diseases with significant unmet need. We also explore the importance of resilience in biotech, the evolution from scientist to CEO, the role AI is beginning to play in drug discovery, and what the future holds for RNA therapeutics and precision medicine.","meta_description":"In this episode of The BioHub by Avetix, I'm joined by Samir Ounzain , CEO and Co-Founder of HAYA Therapeutics . Samir shares the journey from pioneering…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1740,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}